Marginal structural models as a tool for standardization

Epidemiology

Volumn 14, Issue 6, 2003, Pages 680-686

  Sato, Tosiya ^a   Matsuyama, Yutaka ^a  

^a KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

Causal models; Confounding; Epidemiologic methods; Standardization; Weighted analysis

Indexed keywords

ARTICLE; EPIDEMIOLOGICAL DATA; EPIDEMIOLOGY; MATHEMATICAL ANALYSIS; MODEL; PRIORITY JOURNAL; STANDARDIZATION; BREAST TUMOR; FEMALE; HUMAN; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PROBABILITY; RECURRENT DISEASE; RISK; STANDARD;

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TAMOXIFEN;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CAUSALITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; PROBABILITY; RECURRENCE; REFERENCE STANDARDS; RISK; STATISTICS, NONPARAMETRIC; TAMOXIFEN;

EID: 1542472967     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.EDE.0000081989.82616.7d     Document Type: Article

References (16)

1. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol II: The Design and Analysis of Cohort Studies. New York: Oxford University Press; 1987.
2. Rothman KJ, Greenland S. Modern Epidemiology, 2nd Ed. Philadelphia: Lippincott-Raven; 1998.
3. Keiding N. The method of expected number of deaths, 1786-1886-1986. Int Stat Rev. 1987;55:1-20.
4. Miettinen OS. Components of the crude risk ratio. Am J Epidemiol. 1972;96:168-172.
5. Rosenbaum PR, Rubin DB. The central role of propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
6. Greenland S, Robins JM. Identifiability, exchangeability, and epidemiologic confounding. Int J Epidemiol. 1986;15:412-418.
7. Pearl J. Causal diagrams for empirical research. Biometrika. 1995;82:669-688.
8. Flanders WD, Rhodes PH. Large sample confidence intervals for regression standardized risks, risk ratios, and risk differences. J Chron Dis. 1987;40:697-704.
9. Greenland S. Estimating standardized parameters from generalized linear models. Stat Med. 1991;10:1069-1074.
10. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550-560.
11. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of the HIV-positive men. Epidemiology. 2000;11:561-570.
12. Joffe MM, Rosenbaum PR. Propensity scores. Am J Epidemiol. 1999;150:327-333.
13. Greenland S. Interpretation and estimation of summary ratios under heterogeneity. Stat Med. 1982;1:217-227.
14. Matsuyama Y, Tominaga T, Nomura Y, et al. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol. 2000;11:1537-1543.
15. Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In: Halloran E, Berry D, eds. Statistical Models in Epidemiology: The Environment and Clinical Trials. New York: Springer-Verlag 1999:95-134
16. Greenland S. Absence of confounding does not correspond to collapsibility of the rate ratio or rate difference. Epidemiology. 1996;7:498-501.